Dysferlin-deficient muscular dystrophy features amyloidosis

Tools

Item Type:	Article
Title:	Dysferlin-deficient muscular dystrophy features amyloidosis
Creators Name:	Spuler, S., Carl, M., Zabojszcza, J., Straub, V., Bushby, K., Moore, S.A., Bähring, S., Wenzel, K., Vinkemeier, U. and Rocken, C.
Abstract:	OBJECTIVE: Dysferlin (DYSF) gene mutations cause limb girdle muscular dystrophy type 2B and Miyoshi's myopathy. The consequences of DYSF mutations on protein structure are poorly understood. METHODS: The gene encoding dysferlin was sequenced in patients with suspected dysferlin-deficient muscular dystrophy. Muscle biopsy specimens were analyzed by histochemistry, immunohistochemistry, and electron microscopy. Antibodies against N-terminal dysferlin-peptides were raised. RESULTS: We found three families with muscular dystrophy caused by homozygous or compound heterozygous DYSF mutations featuring sarcolemmal and interstitial amyloid deposits. These mutations were all located in the N-terminal region of the protein. Dysferlin was a constituent of the amyloid deposits. INTERPRETATION: Limb girdle muscular dystrophy type 2B is the first muscular dystrophy associated with amyloidosis. Molecular treatment strategies will necessarily have to consider the presence of amyloidogenesis.
Keywords:	Amino Acid Sequence, Amino Acid Substitution, Amyloidosis, Limb-Girdle Muscular Dystrophies, Membrane Proteins, Molecular Sequence Data, Muscle Proteins, Tertiary Protein Structure
Source:	Annals of Neurology
ISSN:	0364-5134
Publisher:	Wiley
Volume:	63
Number:	3
Page Range:	323-328
Date:	March 2008
Official Publication:	https://doi.org/10.1002/ana.21309
PubMed:	View item in PubMed

Repository Staff Only: item control page